Zai Lab Ltd
HKEX:2925
Zai Lab Ltd
HKEX:2925
Price:
0.22
HKD
Market Cap:
HK$5.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zai Lab Ltd
HKEX:2925
|
CN |
|
Bucher Industries AG
SIX:BUCN
|
CH |
|
Varta AG
OTC:VARGF
|
DE |
|
Societal CDMO Inc
F:RAH
|
US |
|
I
|
Intouch Insight Ltd
OTC:INXSF
|
CA |
|
B
|
Beijing Jingkelong Co Ltd
HKEX:814
|
CN |
|
SPAR Group Ltd
OTC:SGPPF
|
ZA |
|
C
|
Comfort Gloves Bhd
KLSE:COMFORT
|
MY |
|
Spectris PLC
LSE:SXS
|
UK |
|
Intrepid Potash Inc
NYSE:IPI
|
US |
|
JD.Com Inc
HKEX:9618
|
CN |
|
Argonaut Resources N L
ASX:ARE
|
AU |
|
K
|
Krystal Integrated Services Ltd
NSE:KRYSTAL
|
IN |
|
M
|
Mutuagung Lestari Tbk PT
IDX:MUTU
|
ID |
|
Sinopec Oilfield Equipment Corp
SZSE:000852
|
CN |
|
Mediaone Global Entertainment Ltd
BSE:503685
|
IN |
|
Atlassian Corporation PLC
NASDAQ:TEAM
|
UK |
|
Farmers National Banc Corp
NASDAQ:FMNB
|
US |
|
Nfon AG
XETRA:NFN
|
DE |
|
B
|
Bien Yapi Urunleri Sanayi Turizm ve Ticaret AS
IST:BIENY.E
|
TR |
|
M
|
Medinex Ltd
SGX:OTX
|
SG |
|
G
|
Grupo Concesionario del Oeste SA
BCBA:OEST
|
AR |
|
S
|
Sharps Technology Inc
NASDAQ:STSS
|
US |
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
NO |
Multiples-Based Value
The
Multiples-Based Value for
Zai Lab Ltd (2925)
under the Base Case is
hidden
HKD.
Compared with the current market price of 0.22 HKD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zai Lab Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Zai Lab Ltd Competitors
Zai Lab Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Zai Lab Ltd
HKEX:2925
|
17.5B HKD | 4.8 | -12.7 | -8.6 | -8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3.1 | 33.7 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
